Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

University of Zurich200 enrolled

Overview

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Hymenoptera Sting Allergy

Interventions

ObservationOTHER

Observation of sting frequency

Eligibility

Sex: ALLMin age: 5 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion criteria: * Bee and/or Wasp allergic patients treated by SIT Exclusion criteria: * None

Locations (1)

Unnamed facility

Zurich, Switzerland

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.